Lentivirus‐mediated silencing of CD133 in human GBM neurospheres has been reported to impair neurosphere cell self‐renewal and tumorigenicity,219 implying that CD133 can be used as a therapeutic target in GBM. This evidence concerns the gene PROM1 and glioblastoma.